Are Pharma Giants Ignoring Clinical Trial Site Issues?

In this episode, Daniel Fox discusses the key challenges faced by research sites, including trust issues, payment delays, and operational setbacks. He emphasizes initiatives like the "Open Mic" policy for anonymous feedback and the grassroots movement Save Our Sites (SOS). Dr. Fox also explores issues with decentralized clinical trials, advocates for patient-centric practices, and underscores the roles of telehealth and AI in research, promoting transparency and ethical standards in clinical research operations. 1. What are the key challenges faced by clinical trial sites?2. How can we ensure that sites have a platform to voice their concerns?3. What is Save our sites?4. Why SCOPE and ACRP may not be suitable platforms for sites?5. How can we address the economics of running a conference when we do need people to buy those slots?6. What is the incentive for individual sites to speak up?7. The Decentralized Clinical Trials Controversy and Citizen Petitions8. The role of Telehealth in Clinical Research9. Does a DCT eliminate the need for localized PIs?10. The Future of AI in Clinical ResearchCheck out Daniel Fox's websites:CRPN- crpn.crpaynet.comSave Our Sites- www.saveoursites.comWhite paper- https://lnkd.in/ek9_NNT7YouTube: @CRPNCentral Support the show

There are no comments yet.

Please log in to write the first comment.